Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma.
Masaoki ItoYoshihiro MiyataShoko HiranoFumiko IrisunaKei KushitaniYuichiro KaiNaoto KishiYasuhiro TsutaniYukio TakeshimaMorihito OkadaPublished in: Journal of cancer research and clinical oncology (2021)
Mutation-targeted liquid biopsy using ddPCR detected lung cancer in 12.0% (12/100) of pN0M0 EGFR-mutant lung adenocarcinoma patients. In 83.3% of the ddPCR-positive patients, tumors showed pure-solid appearance in HRCT. The detection ratio increased to 21.3% (10/47) among patients with pure-solid appearance tumors. Tumor appearance might be useful for better selection of liquid biopsy candidates.